1321 related articles for article (PubMed ID: 17654056)
21. [Advances in immunological aspects of idiopathic thrombocytopenic purpura].
Kuwana M
Nihon Rinsho; 2003 Apr; 61(4):670-5. PubMed ID: 12718094
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis.
Berner B; Wolf G; Hummel KM; Müller GA; Reuss-Borst MA
Ann Rheum Dis; 2000 Mar; 59(3):190-5. PubMed ID: 10700427
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.
Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R
Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715
[TBL] [Abstract][Full Text] [Related]
24. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
Kuwana M; Kaburaki J; Ikeda Y
J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
[TBL] [Abstract][Full Text] [Related]
25. No alteration in T lymphocyte expression of CD40 ligand (CD154) in individuals with or at increased risk for insulin-dependent diabetes mellitus.
Ottendorfer E; Ellis TM; Bahjat KS; Clare-Salzler M; Atkinson MA
J Clin Endocrinol Metab; 1999 Nov; 84(11):4068-72. PubMed ID: 10566651
[TBL] [Abstract][Full Text] [Related]
26. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
Cooper N; Stasi R; Cunningham-Rundles S; Cesarman E; McFarland JG; Bussel JB
Br J Haematol; 2012 Aug; 158(4):539-47. PubMed ID: 22775462
[TBL] [Abstract][Full Text] [Related]
27. Determination of platelet-bound glycoprotein-specific autoantibodies by flow cytometric immunobead assay in primary immune thrombocytopenia.
Liu XG; Li JL; Qin P; Ren J; Ma SH; Sun L; Shi Y; Ji XB; Zhu YY; Ma DX; Guo CS; Du X; Hou M; Peng J
Eur J Haematol; 2011 Apr; 86(4):339-46. PubMed ID: 21198863
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].
Wang L; Zhang F; Zhu YY; Li LZ; Ma DX; Hou M
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3048-51. PubMed ID: 16324405
[TBL] [Abstract][Full Text] [Related]
29. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura.
Wang T; Zhao H; Ren H; Guo J; Xu M; Yang R; Han ZC
Haematologica; 2005 Jul; 90(7):914-23. PubMed ID: 15996929
[TBL] [Abstract][Full Text] [Related]
30. Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients.
Xie J; Cui D; Liu Y; Jin J; Tong H; Wang L; Ruan G; Lu Y; Yuan H
Int J Biol Sci; 2015; 11(2):220-9. PubMed ID: 25561904
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated autoantibodies against platelet-specific receptors.
Tomer A; Koziol J; McMillan R
J Thromb Haemost; 2005 Jan; 3(1):74-8. PubMed ID: 15634268
[TBL] [Abstract][Full Text] [Related]
32. Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura.
Kuwana M; Kawakami Y; Ikeda Y
Blood; 2003 Jan; 101(2):621-3. PubMed ID: 12393517
[TBL] [Abstract][Full Text] [Related]
33. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
[TBL] [Abstract][Full Text] [Related]
34. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
[TBL] [Abstract][Full Text] [Related]
35. Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.
Sakakura M; Wada H; Tawara I; Nobori T; Sugiyama T; Sagawa N; Shiku H
Thromb Res; 2007; 120(2):187-93. PubMed ID: 17067661
[TBL] [Abstract][Full Text] [Related]
36. Estimation of the number of CD154 molecules in membrane extracts used as a source of CD40 stimulation of human B lymphocytes.
Ducas E; Dussault N; Roy A; Dumont N; Néron S
J Immunol Methods; 2009 May; 344(2):133-7. PubMed ID: 19332074
[TBL] [Abstract][Full Text] [Related]
37. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
[TBL] [Abstract][Full Text] [Related]
38. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
40. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.
Han P; McDonald T; Hodge G
Immunology; 2004 Sep; 113(1):26-34. PubMed ID: 15312133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
